Talis Biomedical Company Overview
Talis Biomedical
About Talis Biomedical
Talis Biomedical (NASDAQ:TLIS) focuses on developing and commercializing innovative molecular diagnostic tests for infectious diseases and other conditions. With a commitment to improving patient care, Talis aims to deliver easy-to-use, rapid, and highly accurate testing solutions directly to healthcare professionals and their patients. Their projects include developing the Talis One system, a platform designed to enable high-complexity laboratory testing in various settings outside of traditional laboratories, such as clinics and hospitals. The objective of Talis is to expand the accessibility and impact of molecular diagnostics, supporting timely and informed medical decisions that can significantly affect health outcomes.
What is Talis Biomedical known for?
Snapshot
2013
Year founded
102
Employees
Redwood City, United States
Head office
Loading Map...
Operations
All Locations
United States
Produtos e/ou serviços de Talis Biomedical
- Talis One system for rapid, lab-quality molecular diagnostics at the point of care.
- Development of COVID-19 testing solutions, facilitating quick and accurate detection.
- Research in sexually transmitted infections (STIs) diagnostics for better public health outcomes.
- Advancements in respiratory disease diagnostic technologies, aiming to improve early detection.
- Exploration of assays for women's health, focusing on infections that affect pregnancy and fertility.
- Engagement in antibiotic resistance testing to address global health challenges.
equipe executiva do Talis Biomedical
- Mr. Robert Kelley MBACEO & Director
- Dr. Rustem F. Ismagilov Ph.D.Co-Founder & Director
- Ms. Rebecca MarkovichInterim Chief Financial Officer
- Mr. Liang Li Ph.D.Co-Founder and Director of Technology & Strategy
- Ms. Jill GreenSenior Vice President of Legal
- Ms. Margaret Barrett M.S.Controller
- Gillian GreenCompany Secretary